Detalhe da pesquisa
1.
Long-term outcomes of young, node-negative, chemotherapy-naïve, triple-negative breast cancer patients according to BRCA1 status.
BMC Med
; 22(1): 9, 2024 01 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38191387
2.
Adjuvant capecitabine-containing chemotherapy benefit and homologous recombination deficiency in early-stage triple-negative breast cancer patients.
Br J Cancer
; 126(10): 1401-1409, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35124703
3.
Metabolic Imaging Detects Resistance to PI3Kα Inhibition Mediated by Persistent FOXM1 Expression in ER+ Breast Cancer.
Cancer Cell
; 38(4): 516-533.e9, 2020 10 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32976773